Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-03-19

Clinical Trial Update: The Use of Domperidone for Gastroparesis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating domperidone for gastroparesis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Domperidone (domperidone)

Snippet

Sponsor: Allegiance Health | Conditions: Gastroparesis | Phase 3 | Status: WITHDRAWN